We describe the design of the phase IIb/III trial of TRK-@STP , CASSIOPEIR ( CRF Asian Study with Oral PGI@ derivative for Evaluating Improvement of Renal function ) conducted in approximately @ centers in China , Hong Kong , Japan , Malaysia , Republic of Korea , Taiwan , and Thailand .